CY1108227T1 - Τοπος ελαφρας αλυσιδας λ σε ποντικι - Google Patents

Τοπος ελαφρας αλυσιδας λ σε ποντικι

Info

Publication number
CY1108227T1
CY1108227T1 CY20081100796T CY081100796T CY1108227T1 CY 1108227 T1 CY1108227 T1 CY 1108227T1 CY 20081100796 T CY20081100796 T CY 20081100796T CY 081100796 T CY081100796 T CY 081100796T CY 1108227 T1 CY1108227 T1 CY 1108227T1
Authority
CY
Cyprus
Prior art keywords
light chain
mice
lambda light
place
deleted
Prior art date
Application number
CY20081100796T
Other languages
English (en)
Inventor
Marianne Brüggemann
Xiangang Zou
Original Assignee
Crescendo Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9917128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108227(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Crescendo Biologics Ltd filed Critical Crescendo Biologics Ltd
Publication of CY1108227T1 publication Critical patent/CY1108227T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/054—Animals comprising random inserted nucleic acids (transgenic) inducing loss of function
    • A01K2217/058—Animals comprising random inserted nucleic acids (transgenic) inducing loss of function due to expression of inhibitory nucleic acid, e.g. siRNA, antisense
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Position Input By Displaying (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • User Interface Of Digital Computer (AREA)
  • Details Of Television Scanning (AREA)

Abstract

Η παρούσα εφεύρεση δίδει από μία πρώτη άποψη ένα ποντίκι στο οποίο ο τόπος της ελαφράς αλυσίδας λ (λάμδα) έχει σιγαστεί λειτουργικά. Σε μία εφαρμογή, ο τόπος ελαφράς αλυσίδας λ ποντικιού σιγάστηκε λειτουργικά με τη διαγραφή τμημάτων γονιδίων που κωδικοποιούν τον τόπο ελαφράς αλυσίδας λ. Σε μία περαιτέρω άποψη, παρήχθη ένα ποντίκι που περιέχει λειτουργικά σιγασμένους τόπους L αλυσίδας λ και κ (κάππα). Η εφεύρεση είναι χρήσιμη για την παραγωγή αντισωμάτων, για παράδειγμα ετερόλογων αντισωμάτων, συμπεριλαμβανομένων μόνο των αντισωμάτων βαρείας αλυσίδας.
CY20081100796T 2001-06-21 2008-07-30 Τοπος ελαφρας αλυσιδας λ σε ποντικι CY1108227T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0115256.0A GB0115256D0 (en) 2001-06-21 2001-06-21 Mouse light chain locus
EP02732970.5A EP1399559B2 (en) 2001-06-21 2002-06-21 Mouse lambda light chain locus

Publications (1)

Publication Number Publication Date
CY1108227T1 true CY1108227T1 (el) 2014-02-12

Family

ID=9917128

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100796T CY1108227T1 (el) 2001-06-21 2008-07-30 Τοπος ελαφρας αλυσιδας λ σε ποντικι

Country Status (11)

Country Link
US (4) US7541513B2 (el)
EP (2) EP1956092A1 (el)
AT (1) ATE393826T1 (el)
AU (1) AU2002304460A1 (el)
CY (1) CY1108227T1 (el)
DE (1) DE60226322T3 (el)
DK (1) DK1399559T4 (el)
ES (1) ES2305245T5 (el)
GB (2) GB0115256D0 (el)
PT (1) PT1399559E (el)
WO (1) WO2003000737A2 (el)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0110029D0 (en) 2001-04-24 2001-06-13 Grosveld Frank Transgenic animal
GB0115256D0 (en) * 2001-06-21 2001-08-15 Babraham Inst Mouse light chain locus
GB0228210D0 (en) * 2002-12-03 2003-01-08 Babraham Inst Single chain antibodies
US7141157B2 (en) * 2003-03-11 2006-11-28 Chevron U.S.A. Inc. Blending of low viscosity Fischer-Tropsch base oils and Fischer-Tropsch derived bottoms or bright stock
US8783257B2 (en) 2004-02-23 2014-07-22 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
KR101151957B1 (ko) 2004-07-22 2012-06-01 로저 킹돈 크레이그 결합 분자
DK3738636T3 (da) 2006-07-14 2023-09-11 Fisher & Paykel Healthcare Ltd Åndedrætshjælpeapparat
DK2602323T3 (en) 2007-06-01 2018-04-16 Open Monoclonal Tech Inc Compositions and Methods for Inhibiting Endogenous Immunoglobin Genes and Producing Transgenic Human Idiotypic Antibodies
US10258757B2 (en) 2008-05-12 2019-04-16 Fisher & Paykel Healthcare Limited Patient interface and aspects thereof
US10792451B2 (en) 2008-05-12 2020-10-06 Fisher & Paykel Healthcare Limited Patient interface and aspects thereof
US20100122358A1 (en) * 2008-06-06 2010-05-13 Crescendo Biologics Limited H-Chain-only antibodies
EP3889265A1 (en) 2008-09-30 2021-10-06 Ablexis, LLC Transgenic mice for the production of chimeric antibodies
JP5827127B2 (ja) 2008-12-18 2015-12-02 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム ヒト化抗体を発現する非ヒトトランスジェニック動物及びその使用
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
CN104131035A (zh) 2009-12-10 2014-11-05 瑞泽恩制药公司 生产重链抗体的小鼠
KR102117771B1 (ko) 2010-03-31 2020-06-02 아블렉시스, 엘엘씨 키메라 항체의 제조를 위한 비-인간 동물의 유전적 조작
NZ627119A (en) 2010-06-22 2015-05-29 Regeneron Pharma Hybrid light chain mice
US10793829B2 (en) 2010-07-26 2020-10-06 Trianni, Inc. Transgenic mammals and methods of use thereof
US10662256B2 (en) 2010-07-26 2020-05-26 Trianni, Inc. Transgenic mammals and methods of use thereof
CA2806233C (en) 2010-07-26 2021-12-07 Trianni, Inc. Transgenic animals and methods of use
EP3960865A1 (en) 2010-08-02 2022-03-02 Regeneron Pharmaceuticals, Inc. Mice that make binding proteins comprising vl domains
EP4070841A1 (en) 2010-10-08 2022-10-12 Fisher & Paykel Healthcare Limited Breathing assistance apparatus
WO2012063048A1 (en) 2010-11-08 2012-05-18 Kymab Limited Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
ES2876306T3 (es) 2011-04-15 2021-11-12 Fisher & Paykel Healthcare Ltd Interfaz que comprende una porción de puente nasal replegable en forma de onda
US10603456B2 (en) 2011-04-15 2020-03-31 Fisher & Paykel Healthcare Limited Interface comprising a nasal sealing portion
EP2758534B1 (en) 2011-09-19 2020-04-29 Kymab Limited Animals, repertoires & methods for the production of human antibodies
EP4091442A1 (en) 2011-09-19 2022-11-23 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
WO2013045916A1 (en) 2011-09-26 2013-04-04 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
GB2496375A (en) 2011-10-28 2013-05-15 Kymab Ltd A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
GB201122047D0 (en) 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
KR102038974B1 (ko) 2011-12-20 2019-10-31 리제너론 파마슈티칼스 인코포레이티드 인간화 경쇄 마우스
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
WO2013144567A1 (en) 2012-03-28 2013-10-03 Kymab Limited Transgenic non-human vertebrate for the expression of class - switched, fully human, antibodies
US9980470B2 (en) 2013-03-14 2018-05-29 Erasmus University Medical Center Antibody production
WO2014141192A1 (en) * 2013-03-15 2014-09-18 Erasmus University Medical Center Generation of heavy chain-only antibodies
EP3119194B1 (en) 2014-03-21 2021-04-28 Regeneron Pharmaceuticals, Inc. Non-human animals that make single domain binding proteins
BR112016021679A2 (pt) 2014-03-21 2018-12-04 Regeneron Pharmaceuticals, Inc. proteína de ligação ao antígeno, métodos de produção de uma proteína de ligação ao antígeno e de identificação de uma ou mais proteínas de ligação ao antígeno, hibridoma, ácido nucleico, célula, e, animal não humano geneticamente modificado.
AU2014409276A1 (en) 2014-10-22 2017-04-06 Crescendo Biologics Limited Transgenic mice
GB201500461D0 (en) 2015-01-12 2015-02-25 Cresendo Biolog Ltd Therapeutic molecules
GB201500464D0 (en) 2015-01-12 2015-02-25 Crescendo Biolog Ltd Method of producing optimised therapeutic molecules
AU2016232715A1 (en) 2015-03-19 2017-09-28 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
WO2017095939A1 (en) 2015-12-03 2017-06-08 Trianni, Inc. Enhanced immunoglobulin diversity
CN108473589B (zh) 2016-01-12 2023-05-02 克雷森多生物制剂有限公司 结合前列腺特异性膜抗原(psma)的分子
WO2017136734A1 (en) 2016-02-04 2017-08-10 Trianni, Inc. Enhanced production of immunoglobulins
EP3471773A4 (en) 2016-06-21 2020-07-08 Teneobio, Inc. ANTIBODIES BINDING CD3
GB201612043D0 (en) 2016-07-11 2016-08-24 Crescendo Biologics Ltd Composition for treatment of disorders
KR20190052006A (ko) 2016-08-24 2019-05-15 테네오바이오, 인코포레이티드 변형된 중쇄-단독 항체를 생산하는 형질전환 비-인간 동물
JP7030109B2 (ja) 2016-09-14 2022-03-04 テネオバイオ， インコーポレイテッド Ｃｄ３結合抗体
US20230137351A1 (en) 2016-11-14 2023-05-04 Amgen Inc. Bispecific or biparatopic antigen binding proteins and uses thereof
WO2018119215A1 (en) 2016-12-21 2018-06-28 Teneobio, Inc. Anti-bcma heavy chain-only antibodies
WO2018127710A1 (en) 2017-01-06 2018-07-12 Crescendo Biologics Limited Single domain antibodies to programmed cell death (pd-1)
USD824020S1 (en) 2017-02-23 2018-07-24 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
USD823455S1 (en) 2017-02-23 2018-07-17 Fisher & Paykel Healthcare Limited Cushion assembly for breathing mask assembly
EP3642236A1 (en) 2017-06-20 2020-04-29 TeneoOne, Inc. Anti-bcma heavy chain-only antibodies
EP3642237A2 (en) 2017-06-20 2020-04-29 Teneobio, Inc. Anti-bcma heavy chain-only antibodies
GB201711068D0 (en) 2017-07-10 2017-08-23 Crescendo Biologics Ltd Therapeutic molecules binding PSMA
SG11202002093TA (en) 2017-09-13 2020-04-29 Teneobio Inc Heavy chain antibodies binding to ectoenzymes
WO2019092452A1 (en) 2017-11-13 2019-05-16 Crescendo Biologics Limited Molecules that bind to cd137 and psma
KR20200104342A (ko) 2017-12-22 2020-09-03 테네오바이오, 인코포레이티드 Cd22에 결합하는 중쇄 항체
GB201802573D0 (en) 2018-02-16 2018-04-04 Crescendo Biologics Ltd Therapeutic molecules that bind to LAG3
JP7439046B2 (ja) 2018-07-20 2024-02-27 テネオツー・インコーポレイテッド Ｃｄ１９に結合する重鎖抗体
GB2576914A (en) 2018-09-06 2020-03-11 Kymab Ltd Antigen-binding molecules comprising unpaired variable domains produced in mammals
US20210388106A1 (en) 2018-10-26 2021-12-16 Teneobio, Inc. Heavy chain antibodies binding to cd38
GB201818460D0 (en) 2018-11-13 2018-12-26 Crescendo Biologics Ltd Single domain antibodies that bind human serum albumin
KR20210133234A (ko) 2019-02-18 2021-11-05 바이오사이토젠 파마슈티컬스 (베이징) 컴퍼니 리미티드 인간화 면역글로불린 유전자좌를 갖는 유전적으로 변형된 비-인간 동물
CR20210500A (es) 2019-04-05 2021-11-05 Teneobio Inc Anticuerpos de cadena pesada que se unen al psma
US20220220215A1 (en) 2019-05-15 2022-07-14 Crescendo Biologics Limited Binding molecules
AR119746A1 (es) 2019-06-14 2022-01-05 Teneobio Inc Anticuerpos multiespecíficos de cadena pesada que se unen a cd22 y cd3
GB201914468D0 (en) 2019-10-07 2019-11-20 Crescendo Biologics Ltd Binding Molecules
IL293751A (en) 2019-12-18 2022-08-01 Teneofour Inc Heavy chain antibodies that bind to cd38
WO2021222578A1 (en) 2020-04-29 2021-11-04 Teneobio, Inc. Multispecific heavy chain antibodies with modified heavy chain constant regions
BR112022021690A2 (pt) 2020-04-29 2022-12-20 Teneobio Inc Anticorpos de cadeia pesada multispecíficos com regiões constantes de cadeia pesada modificadas
US20220411504A1 (en) 2020-05-27 2022-12-29 Janssen Biotech, Inc. Proteins comprising cd3 antigen binding domains and uses thereof
IL298632A (en) 2020-06-02 2023-01-01 Biocytogen Pharmaceuticals Beijing Co Ltd Non-human animals genetically modified with a common light chain immunoglobulin locus
AU2021300179A1 (en) 2020-06-30 2023-02-02 Teneobio, Inc. Multi-specific antibodies binding to BCMA
TW202233684A (zh) 2020-11-18 2022-09-01 美商泰尼歐生物公司 結合於葉酸受體α之重鏈抗體
WO2022183074A2 (en) 2021-02-25 2022-09-01 Teneobio, Inc. Anti-psma antibodies and car-t structures
CA3211142A1 (en) 2021-02-26 2022-09-01 Teneobio, Inc. Anti-muc1-c antibodies and car-t structures
TW202304994A (zh) 2021-04-02 2023-02-01 美商泰尼歐生物公司 促效性抗ｉｌ－２ｒ抗體及使用方法
CA3214283A1 (en) 2021-04-06 2022-10-13 Teneobio, Inc. Anti-cd19 antibodies and car-t structures
WO2022221698A1 (en) 2021-04-16 2022-10-20 Teneobio, Inc. Anti-cd20 antibodies and car-t structures
WO2022271987A1 (en) 2021-06-23 2022-12-29 TeneoFour, Inc. Anti-cd38 antibodies and epitopes of same
WO2023004197A1 (en) 2021-07-23 2023-01-26 Teneoten, Inc. Heavy chain antibodies binding to hepatitis b surface antigen
GB202205589D0 (en) 2022-04-14 2022-06-01 Crescendo Biologics Ltd Mesothelin binders
WO2023199069A1 (en) 2022-04-14 2023-10-19 Crescendo Biologics Limited Chimeric antigen receptor that binds mesothelin
WO2024077044A1 (en) 2022-10-05 2024-04-11 Amgen Inc. Combination therapies comprising t-cell redirecting therapies and agonistic anti-il-2r antibodies or fragments thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US6673986B1 (en) * 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US6300129B1 (en) * 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1994002602A1 (en) * 1992-07-24 1994-02-03 Cell Genesys, Inc. Generation of xenogeneic antibodies
KR100654645B1 (ko) * 1995-04-27 2007-04-04 아브게닉스, 인크. 면역화된 제노마우스 유래의 인간 항체
GB9823930D0 (en) 1998-11-03 1998-12-30 Babraham Inst Murine expression of human ig\ locus
IL154751A0 (en) 2000-08-03 2003-10-31 Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
GB0110029D0 (en) 2001-04-24 2001-06-13 Grosveld Frank Transgenic animal
GB0115256D0 (en) * 2001-06-21 2001-08-15 Babraham Inst Mouse light chain locus
DK1399484T3 (da) 2001-06-28 2010-11-08 Domantis Ltd Dobbelt-specifik ligand og anvendelse af denne
GB0228210D0 (en) 2002-12-03 2003-01-08 Babraham Inst Single chain antibodies

Also Published As

Publication number Publication date
US20050060763A1 (en) 2005-03-17
EP1399559A2 (en) 2004-03-24
US20170049083A1 (en) 2017-02-23
EP1399559B2 (en) 2015-09-02
DE60226322T2 (de) 2009-07-09
US8367888B2 (en) 2013-02-05
GB0115256D0 (en) 2001-08-15
GB0400676D0 (en) 2004-02-18
EP1399559B1 (en) 2008-04-30
ES2305245T3 (es) 2008-11-01
DK1399559T4 (en) 2015-12-14
PT1399559E (pt) 2008-07-29
ATE393826T1 (de) 2008-05-15
US20130046079A1 (en) 2013-02-21
EP1956092A1 (en) 2008-08-13
GB2392672B (en) 2005-05-11
GB2392672A (en) 2004-03-10
US7541513B2 (en) 2009-06-02
DK1399559T3 (da) 2008-08-25
WO2003000737A2 (en) 2003-01-03
DE60226322D1 (de) 2008-06-12
AU2002304460A1 (en) 2003-01-08
DE60226322T3 (de) 2016-03-03
ES2305245T5 (es) 2015-12-11
US20110093961A1 (en) 2011-04-21
US9439405B2 (en) 2016-09-13
WO2003000737A3 (en) 2003-09-25
US10194645B2 (en) 2019-02-05

Similar Documents

Publication Publication Date Title
CY1108227T1 (el) Τοπος ελαφρας αλυσιδας λ σε ποντικι
ATE344323T1 (de) Transgene mäuse, die den menschliche immunoglobulinlambdalokus exprimieren
ATE411082T1 (de) Neue verwendung von kurzkettigen carbonsäuren
ATE510854T1 (de) Lineares, schweres antikörperkettenfragment vh- ch1-vh-ch1
ATE280228T1 (de) Monoklonaler antikörper gegen rhesus d (d7c2)
DE60116510D1 (de) Cyaninfarbstoffe
CY1114197T1 (el) Μεθοδος διαμορφωσης της δραστικοτητας λειτουργικων ανοσομοριων
DK199901178A (da) Benzinsvovl-reduktion ved fluid-katalytisk krakning
CY1109593T1 (el) Παραγωγα 12,13-κυκλοπροπανο εποθιλονης
EA200400510A1 (ru) Агенты, специфически связывающие ангиопоэтин-2
ATE531812T1 (de) Humanisierung von nager-antikörpern
DK1354034T3 (da) Transgene transchromosomale gnavere til fremstilling af humane antistoffer
HK1069586A1 (en) Anti-her2 antibody variants anti-her2
DK1078004T3 (da) Tetravalente antistof-konstrukter
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
WO2005003171A3 (en) Modified antibody fragments
DE60129891D1 (de) Wellenform für den Abwärtsstrahl einer Antenna mit Strahlensprung
BR0208235B1 (pt) processo para produzir uma fraÇço de combustÍvel diesel a partir de betume.
ID30599A (id) Metode pengevaluasian putihnya, metode pengevaluasian pembanding putihnya, sumber cahaya dan luminaire
ATE517926T1 (de) Antikörper zur hemmung der aktivität von mmp-2 und mmp-9
DE60110361D1 (de) Polytrimethylenterephthalat-stapelfasern mit tetrakanalquerschnitt
EA200101130A1 (ru) Общие пролекарства амлодипина и аторвастатина
NO993647L (no) Endotelinantagonist
ATE533009T1 (de) Lanterneuanordnung
DE29712026U1 (de) Brenner für die Verbrennung von Abgasen mit mindestens einer kondensationsfähigen Komponente